CN1160107C - Weight-lossing hypolipemic medicine - Google Patents
Weight-lossing hypolipemic medicine Download PDFInfo
- Publication number
- CN1160107C CN1160107C CNB021177546A CN02117754A CN1160107C CN 1160107 C CN1160107 C CN 1160107C CN B021177546 A CNB021177546 A CN B021177546A CN 02117754 A CN02117754 A CN 02117754A CN 1160107 C CN1160107 C CN 1160107C
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- fructus
- parched
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a weight-losing fat-reducing medicine which is in the form of powder or pills and is prepared from solomonseal rhizome, polygonatum, seaweed, blackfungus, dried alum, soap pod, Chinese date, rhubarb, stir-frying largehead atractylodes rhizome, tuckahoe, water plantain, stir-frying semen coicis, glabrous greenbrier rhizome, astragalus root, wolfberry fruit, prepared fleece flower root, epimedium, leech, peach kernel, green tea, cassia bark, dry lotus leaf, stir-frying immature bitter orange and calamus as raw materials in a conventional method. The medicine has the functions of phlegm resolving, qi supplementation, kidney nourishing, spleen and stomach harmonization, promotion of the decomposition of fat tissues and inhibition of the synthesis of fat tissues so as to enable fat metabolism to be balanced. The medicine is suitable for patients of simple obesity accompanied with hyperlipemia and hyperglycemia to take and has the advantages of obvious effect, no diarrhea, no weakness feeling and no rebound.
Description
(1) technical field
The present invention relates to a kind of Weight-lossing hypolipemic medicine, belong to field of medicaments.
(2) background technology
Raising along with people's life, pay attention to the healthy of individual more, but some person quality and dietary structure mismate will produce obesity, edible for a long time high-fat food, cause athero, metabolism is obstructed, and in the course of time, body constitution descends, work load is heavier, even also can cause multiple disease such as diabetes, hypertension, coronary heart disease, so Weight-reducing and lipid-lowering more and more is subjected to people's favor, the slimming medicine kind is a lot of in the market, have at poor, effect is undesirable, and what have costs an arm and a leg, and ordinary people's financial burden is overweight, also some side effect that has, even also have rebound phenomena to take place.
(3) summary of the invention
Purpose of the present invention is the shortcoming and deficiency in order to overcome above-mentioned prior art just, and provide a kind of fatty tissue that makes to decompose, can suppress the synthetic Weight-lossing hypolipemic medicine of fatty tissue again, thereby effectively treatment of obesity recovers healthy rapidly, also prevents the generation of multiple disease simultaneously.
The objective of the invention is to realize by following technical proposal:
Weight-lossing hypolipemic medicine is characterized in that it is the medicament of being made by the following weight proportion raw material,
Rhizoma Polygonati 120-150 part, Rhizoma Polygonati Odorati 80-100 part, Sargassum 80-100 part, Auricularia 80-100 part, dried Alumen 20-40 part, Fructus Gleditsia 80-100 part, Fructus Jujubae 50-100 part, Radix Et Rhizoma Rhei 15-60 part, Rhizoma Atractylodis Macrocephalae (parched) 50-100 part, Poria 60-90 part, Rhizoma Alismatis 100-150 part, fry Semen Coicis 60-120 part, Rhizoma Smilacis Glabrae 80-120 part, Radix Astragali 100-150 part, Fructus Lycii 60-90 part, Radix Polygoni Multiflori Preparata 80-150 part, Herba Epimedii 80-100 part, Hirudo 40-100 part, Semen Persicae 80-150 part, green tea 80-100 part, Cortex Cinnamomi 40-80 part, dry Folium Nelumbinis 60-150 part, Fructus Aurantii Immaturus (parched) 40-120 part, Rhizoma Acori Graminei 80-100 part.
The formula optimization weight proportion scope of medicine of the present invention is:
Rhizoma Polygonati 120-140 part, Rhizoma Polygonati Odorati 90-100 part, Sargassum 90-100 part, Auricularia 90-100 part, dried Alumen 25-35 part, Fructus Gleditsia 90-100 part, Fructus Jujubae 60-80 part, Radix Et Rhizoma Rhei 20-50 part, Rhizoma Atractylodis Macrocephalae (parched) 60-80 part, Poria 60-80 part, Rhizoma Alismatis 120-150 part, fry Semen Coicis 80-100 part, Rhizoma Smilacis Glabrae 90-100 part, Radix Astragali 120-150 part, Fructus Lycii 70-80 part, Radix Polygoni Multiflori Preparata 100-150 part, Herba Epimedii 90-100 part, Hirudo 50-80 part, Semen Persicae 100-120 part, green tea 80-90 part, Cortex Cinnamomi 50-70 part, dry Folium Nelumbinis 80-120 part, fry real 50-100 part, Rhizoma Acori Graminei 90-100 part.
The optimum weight proportioning of medicine of the present invention is:
130 parts of Rhizoma Polygonatis, 90 parts of Rhizoma Polygonati Odorati, 90 parts of Sargassums, 100 parts of Auricularia, 30 parts of dried Alumens, 90 parts in Fructus Gleditsia, 80 parts in Fructus Jujubae, 40 parts of Radix Et Rhizoma Rhei, 70 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 70 parts in Poria, 130 parts of Rhizoma Alismatis, 90 parts of Semen Coicis of stir-fry, 100 parts of Rhizoma Smilacis Glabraes, 130 parts of the Radixs Astragali, 80 parts of Fructus Lycii, 120 parts of Radix Polygoni Multiflori Preparata, 90 parts of Herba Epimedii, 70 parts of Hirudos, 110 parts in Semen Persicae, 90 parts of green tea, 60 parts of Cortex Cinnamomis, 90 parts of dry Folium Nelumbinis, 80 parts of Fructus Aurantii Immaturus (parched), 90 parts of Rhizoma Acori Gramineis.
Described medicament is a said dosage form on any pharmaceutics; Described medicament is powder, pill.
Medicine of the present invention is to be foundation with modern genetics achievement in research, the prescription that the utilization theory of Chinese medical science is summed up through for many years clinical practice, employing is reduced phlegm, the QI invigorating the kidney invigorating, adjust taste, reach the decomposition that promotes fatty tissue and suppress the synthetic of fatty tissue, reach and make lipometabolic tending to balance, Rhizoma Polygonati in the prescription, Rhizoma Polygonati Odorati, Sargassum, Auricularia, be monarch drug, dried Alumen, Fructus Gleditsia, Fructus Jujubae, Radix Et Rhizoma Rhei, Rhizoma Atractylodis Macrocephalae (parched), Poria, Rhizoma Alismatis, fry Semen Coicis, Rhizoma Smilacis Glabrae, the Radix Astragali is a ministerial drug, Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Hirudo, Semen Persicae, green tea is adjuvant drug, Cortex Cinnamomi, dry Folium Nelumbinis, Fructus Aurantii Immaturus (parched), Rhizoma Acori Graminei is a messenger drug, monarch, compatibility are reasonable in order.Wherein four monarchs drug all have the effect of obvious weight reducing, and Rhizoma Polygonati is the medicine of the traditional Chinese medical science QI invigorating of spleen reinforcing lung moistening, Rhizoma Polygonati clothes for a long time is oiliness not dry, above-mentioned four Chinese medicine all records the merit medicine of weight reducing in " draft detailed outline ", but taking for a long time and having causes cloudy gas to cross resembling of Sheng and phlegm-damp, so our adapted dried Alumen, Fructus Gleditsia is with invigorating the spleen for dissipating phlegm, blood fat reducing, because fat people's excessive phlegm is wet, use Rhizoma Atractylodis Macrocephalae (parched), Poria, Rhizoma Alismatis, fry Semen Coicis, Radix Et Rhizoma Rhei, it is wet that but the Rhizoma Smilacis Glabrae spleen invigorating is eliminated the phlegm, solved fat people's main diseases because of, the many deficiency of vital energys of fat people and appetrol all have the catharsis effect simultaneously, therefore adopt heavy dose of Radix Astragali QI invigorating, it is no weak after patient is taken medicine, there is not side effect such as breathe hard, with Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, the liver nourishing of holding concurrently of the deficiency of kidney-replenishing, make the kidney qi foot, irritability is relaxed and is equipped with Hirudo again, Semen Persicae, but green tea blood circulation promoting and blood stasis dispelling, fatty tissue is decomposed quicken to support discharge as early as possible, we select the medicine of several tying-ins, Cortex Cinnamomi guiding fire to origin wherein, can make the sufficient insufficiency of the spleen improvement of kidney yang, dry Folium Nelumbinis the lucid yang sending up gas, Fructus Aurantii Immaturus (parched) the turbid descending gas, one rise and one drop like this, ascending the clear and descending the turbid make spleen and stomach function normal, and the fat talent can really reduce superabundant fats, reduce phlegm by Rhizoma Acori Graminei at last, borrow the Folium Nelumbinis the lucid yang sending up to have one's ideas straightened out in brain, and brain lipogenesis maincenter is also had regulating action, full side had both solved many deficiency of vital energys of fat people, excessive phlegm is wet, the symptom of many blood stasis, again by invigorating the spleen for dissipating phlegm, QI invigorating, the kidney warming liver nourishing is decomposed superabundant fats, and negative and positive belong to balance.
Clinical observation result:
Obese patient's 80 examples, male 24 examples, women 56 examples, age 18-58, body weight 70-110kg, Therapeutic Method are oral on an empty stomach sooner or later, twice of every day.Each 10g watered pill, one month is a course of treatment, general 1-3 course of treatment.
The treatment standard:
Produce effects: average weight alleviates the above person of 4kg;
Effectively: average weight alleviates the above person of 2kg;
Invalid: the body weight no change.
Therapeutic outcome:
Produce effects 60 examples account for 75%, effective 18 examples 22.5%, invalid 2 examples 2.5%, total effective rate 97.5%.
Owing to take technique scheme to make the technology of the present invention compared with the prior art have following advantage and effect:
A) pharmaceutical formulation monarch of the present invention, medication is reasonable, and the compatibility science is suited the remedy to the case;
B) therapeutic effect is good, and effective percentage can reach more than 97%, and without any side effects, does not rebound.
(5) specific embodiment
Embodiment 1
Get Rhizoma Polygonati 120g, Rhizoma Polygonati Odorati 100g, Sargassum 80g, Auricularia 100g, dried Alumen 20g, Fructus Gleditsia 80g, Fructus Jujubae 100g, Radix Et Rhizoma Rhei 15g, Rhizoma Atractylodis Macrocephalae (parched) 40g, Poria 90g, Rhizoma Alismatis 100g, fry Semen Coicis 120g, Rhizoma Smilacis Glabrae 80g, Radix Astragali 150g, Fructus Lycii 60g, Radix Polygoni Multiflori Preparata 150g, Herba Epimedii 80g, Hirudo 100g, Semen Persicae 80g, green tea 100g, Cortex Cinnamomi 40g, dry Folium Nelumbinis 150g, Fructus Aurantii Immaturus (parched) 40g, Rhizoma Acori Graminei 100g, make powder according to a conventional method after above-mentioned raw materials is mixed.
Embodiment 2
Get Rhizoma Polygonati 130g, Rhizoma Polygonati Odorati 90g, Sargassum 90g, Auricularia 90g, dried Alumen 30g, Fructus Gleditsia 90g, Fructus Jujubae 80g, Radix Et Rhizoma Rhei 40g, Rhizoma Atractylodis Macrocephalae (parched) 30g, Poria 70g, Rhizoma Alismatis 130g, fry Semen Coicis 90g, Rhizoma Smilacis Glabrae 100g, Radix Astragali 130g, Fructus Lycii 80g, Radix Polygoni Multiflori Preparata 120g, Herba Epimedii 90g, Hirudo 70g, Semen Persicae 110g, green tea 90g, Cortex Cinnamomi 60g, dry Folium Nelumbinis 90g, Fructus Aurantii Immaturus (parched) 80g, Rhizoma Acori Graminei 90g, make pill according to a conventional method after above-mentioned raw materials is mixed.
Embodiment 3
Get Rhizoma Polygonati 150g, Rhizoma Polygonati Odorati 80g, Sargassum 100g, Auricularia 80g, dried Alumen 40g, Fructus Gleditsia 100g, Fructus Jujubae 50g, Radix Et Rhizoma Rhei 60g, Rhizoma Atractylodis Macrocephalae (parched) 20g, Poria 60g, Rhizoma Alismatis 1 50g, fry Semen Coicis 60g, Rhizoma Smilacis Glabrae 120g, Radix Astragali 100g, Fructus Lycii 90g, Radix Polygoni Multiflori Preparata 80g, Herba Epimedii 100g, Hirudo 40g, Semen Persicae 150g, green tea 80g, Cortex Cinnamomi 80g, dry Folium Nelumbinis 60g, Fructus Aurantii Immaturus (parched) 120g, Rhizoma Acori Graminei 80g, make powder according to a conventional method after above-mentioned raw materials is mixed.
Claims (4)
1, a kind of Weight-lossing hypolipemic medicine is characterized in that it is the medicament of being made by the following weight proportion raw material,
Rhizoma Polygonati 120-150 part, Rhizoma Polygonati Odorati 80-100 part, Sargassum 80-100 part, Auricularia 80-100 part, dried Alumen 20-40 part, Fructus Gleditsia 80-100 part, Fructus Jujubae 50-100 part, Radix Et Rhizoma Rhei 15-60 part, Rhizoma Atractylodis Macrocephalae (parched) 50-100 part, Poria 60-90 part, Rhizoma Alismatis 100-150 part, fry Semen Coicis 60-120 part, Rhizoma Smilacis Glabrae 80-120 part, Radix Astragali 100-150 part, Fructus Lycii 60-90 part, Radix Polygoni Multiflori Preparata 80-150 part, Herba Epimedii 80-100 part, Hirudo 40-100 part, Semen Persicae 80-150 part, green tea 80-100 part, Cortex Cinnamomi 40-80 part, dry Folium Nelumbinis 60-150 part, Fructus Aurantii Immaturus (parched) 40-120 part, Rhizoma Acori Graminei 80-100 part.
2, Weight-lossing hypolipemic medicine according to claim 1 is characterized in that, wherein the weight proportion of raw material is:
Rhizoma Polygonati 120-140 part, Rhizoma Polygonati Odorati 90-100 part, Sargassum 90-100 part, Auricularia 90-100 part, dried Alumen 25-35 part, Fructus Gleditsia 90-100 part, Fructus Jujubae 60-80 part, Radix Et Rhizoma Rhei 20-50 part, Rhizoma Atractylodis Macrocephalae (parched) 60-80 part, Poria 60-80 part, Rhizoma Alismatis 120-150 part, fry Semen Coicis 80-100 part, Rhizoma Smilacis Glabrae 90-100 part, Radix Astragali 120-150 part, Fructus Lycii 70-80 part, Radix Polygoni Multiflori Preparata 100-150 part, Herba Epimedii 90-100 part, Hirudo 50-80 part, Semen Persicae 100-120 part, green tea 80-90 part, Cortex Cinnamomi 50-70 part, dry Folium Nelumbinis 80-120 part, Fructus Aurantii Immaturus (parched) 50-100 part, Rhizoma Acori Graminei 90-100 part.
3, Weight-lossing hypolipemic medicine according to claim 1 is characterized in that, wherein the weight proportion of raw material is:
130 parts of Rhizoma Polygonatis, 90 parts of Rhizoma Polygonati Odorati, 90 parts of Sargassums, 100 parts of Auricularia, 30 parts of dried Alumens, 90 parts in Fructus Gleditsia, 80 parts in Fructus Jujubae, 40 parts of Radix Et Rhizoma Rhei, 70 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 70 parts in Poria, 130 parts of Rhizoma Alismatis, 90 parts of Semen Coicis of stir-fry, 100 parts of Rhizoma Smilacis Glabraes, 130 parts of the Radixs Astragali, 80 parts of Fructus Lycii, 120 parts of Radix Polygoni Multiflori Preparata, 90 parts of Herba Epimedii, 70 parts of Hirudos, 110 parts in Semen Persicae, 90 parts of green tea, 60 parts of Cortex Cinnamomis, 90 parts of dry Folium Nelumbinis, 80 parts of Fructus Aurantii Immaturus (parched), 90 parts of Rhizoma Acori Gramineis.
4,, it is characterized in that described medicament is powder or pill according to claim 1,2 or 3 described Weight-lossing hypolipemic medicines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021177546A CN1160107C (en) | 2002-05-16 | 2002-05-16 | Weight-lossing hypolipemic medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021177546A CN1160107C (en) | 2002-05-16 | 2002-05-16 | Weight-lossing hypolipemic medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1381263A CN1381263A (en) | 2002-11-27 |
CN1160107C true CN1160107C (en) | 2004-08-04 |
Family
ID=4744512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021177546A Expired - Fee Related CN1160107C (en) | 2002-05-16 | 2002-05-16 | Weight-lossing hypolipemic medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1160107C (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167973B (en) * | 2007-10-26 | 2011-06-15 | 马万凯 | Traditional Chinese medicine for treating hyperlipemia |
CN101259191B (en) * | 2008-04-18 | 2010-12-29 | 南宁中诺生物工程有限责任公司 | Fat-reducing health products and producing method thereof |
CN103301436B (en) * | 2013-06-21 | 2015-01-07 | 王燕华 | Medicine for loosing weight and reducing fat |
CN103463531B (en) * | 2013-09-27 | 2015-03-11 | 张清峰 | Use of rhizoma smilacis glabrae extract in preparation of lipid-lowering and fat-reducing medicines and health-care foods |
CN104012707B (en) * | 2014-06-21 | 2015-10-21 | 黄荣波 | A kind of Chinese medicinal tea for losing weight with blood fat reducing function |
CN104012712B (en) * | 2014-06-21 | 2015-09-30 | 宁波市江东御品茶叶商行 | A kind of Chinese medicinal tea for losing weight with blood fat reducing function |
CN104012710A (en) * | 2014-06-21 | 2014-09-03 | 朱玉芳 | Chinese herbal medicinal weight reducing tea with blood fat reducing effect |
CN105381424A (en) * | 2015-11-21 | 2016-03-09 | 赵丙海 | Traditional Chinese medicine for detoxifying human viscera and preparation method of traditional Chinese medicine |
CN106177448A (en) * | 2016-09-12 | 2016-12-07 | 广西南宁乐蕊生物科技有限责任公司 | A kind of Chinese medicine for losing weight decoction |
CN113854560A (en) * | 2021-09-26 | 2021-12-31 | 广州巨咖时代科技有限公司 | Weight-losing formula and preparation method |
-
2002
- 2002-05-16 CN CNB021177546A patent/CN1160107C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1381263A (en) | 2002-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100339123C (en) | Traditional Chinese medicine liquor and preparation method thereof | |
CN101468171B (en) | Medicament for weight-reducing of fat people and weight-gaining of thin people | |
CN101347563B (en) | Medicament for treating baldness and white hair and preparation method thereof | |
CN101485830B (en) | Pure Chinese medicine anti-aging health-care capsule | |
CN102258710B (en) | Traditional Chinese medicine composition for treating type II diabetes | |
CN1160107C (en) | Weight-lossing hypolipemic medicine | |
CN101041050A (en) | Chinese traditional medicine compound took orally for treating chronic gastritis | |
CN101732512A (en) | Weight-reducing Chinese medicinal preparation | |
CN101062329A (en) | Chinese traditional medicine massaging ointment for losing weight and the preparing method thereof | |
CN105125851A (en) | Traditional Chinese medicine treating 2-type diabetes and preparation technology | |
CN101642523A (en) | Chinese patent medicine for treating cardiovascular and cerebrovascular diseases | |
CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
CN101612223A (en) | Traditional Chinese medicine for benefiting heart and strengthening brain | |
CN101062221B (en) | Medicine for treating gastric ulcer and duodenal ulcer | |
CN101062339A (en) | Medicine for treating diabetes | |
CN1056295C (en) | Chinese medicine prepn for balancing internal secretion | |
CN101288726A (en) | Medicine composition for adjusting blood fat and its preparation method | |
CN111110735A (en) | Lipid-lowering pharmaceutical composition, preparation method and application | |
CN102688445A (en) | Traditional Chinese medicine for treating diabetes and preparation method thereof | |
CN1305816A (en) | Medicine for treating diabetes | |
CN102327572A (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
CN103127437B (en) | Traditional Chinese medicine composition having hypoglycemic effect | |
CN101757421A (en) | Traditional Chinese medicine composite for treating obesity | |
CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
CN101912434A (en) | Medicament for treating hypertension and insomnia and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |